These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35714532)

  • 1. Fentanyl preference among people who use opioids in New York City.
    Urmanche AA; Beharie N; Harocopos A
    Drug Alcohol Depend; 2022 Aug; 237():109519. PubMed ID: 35714532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.
    Silverstein SM; Daniulaityte R; Martins SS; Miller SC; Carlson RG
    Int J Drug Policy; 2019 Dec; 74():76-83. PubMed ID: 31563098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "They say it's fentanyl, but they honestly look like Perc 30s": Initiation and use of counterfeit fentanyl pills.
    Daniulaityte R; Sweeney K; Ki S; Doebbeling BN; Mendoza N
    Harm Reduct J; 2022 May; 19(1):52. PubMed ID: 35614447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.
    McKnight C; Des Jarlais DC
    Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City.
    Beharie N; Urmanche A; Harocopos A
    Harm Reduct J; 2023 Mar; 20(1):38. PubMed ID: 36966342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding intentionality of fentanyl use and drug overdose risk: Findings from a mixed methods study of people who inject drugs in New York City.
    McKnight C; Weng CA; Reynoso M; Kimball S; Thompson LM; Jarlais DD
    Int J Drug Policy; 2023 Aug; 118():104063. PubMed ID: 37270373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology.
    Daniulaityte R; Carlson RR; Juhascik MP; Strayer KE; Sizemore IE
    Int J Drug Policy; 2019 Sep; 71():3-9. PubMed ID: 31146200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
    Carroll JJ; Marshall BDL; Rich JD; Green TC
    Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities.
    Morales KB; Park JN; Glick JL; Rouhani S; Green TC; Sherman SG
    Drug Alcohol Depend; 2019 Nov; 204():107547. PubMed ID: 31536877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs.
    Reed MK; Guth A; Salcedo VJ; Hom JK; Rising KL
    Int J Drug Policy; 2022 May; 103():103643. PubMed ID: 35255392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK; Salcedo VJ; Guth A; Rising KL
    J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks.
    Daniulaityte R; Silverstein SM; Getz K; Juhascik M; McElhinny M; Dudley S
    Int J Drug Policy; 2022 Jan; 99():103463. PubMed ID: 34619443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana.
    Friedman J; Bourgois P; Godvin M; Chavez A; Pacheco L; Segovia LA; Beletsky L; Arredondo J
    Int J Drug Policy; 2022 Jun; 104():103678. PubMed ID: 35421740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and correlates of fentanyl preferences among people with opioid use disorder.
    Hochstatter KR; Terplan M; Mitchell SG; Schwartz RP; Dusek K; Wireman K; Gryczynski J
    Drug Alcohol Depend; 2022 Nov; 240():109630. PubMed ID: 36152404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market.
    Weicker NP; Owczarzak J; Urquhart G; Park JN; Rouhani S; Ling R; Morris M; Sherman SG
    Int J Drug Policy; 2020 Oct; 84():102900. PubMed ID: 32769054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.
    Glick JL; Christensen T; Park JN; McKenzie M; Green TC; Sherman SG
    Drug Alcohol Depend; 2019 Jan; 194():527-532. PubMed ID: 30551090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.